Target intelligence / Profile preview

Avibacterium paragallinarum (A. paragallinarum)

Target
A. paragallinarum
Molecular classification
Other, Bacterial pathogen
01

Overview

Avibacterium paragallinarum is a Gram-negative, pleomorphic, non-motile bacterium that serves as the primary causative agent of infectious coryza, an acute respiratory disease in chickens [1]. Formerly known as Haemophilus paragallinarum, this pathogen is characterized by its requirement for nicotinamide adenine dinucleotide (NAD or V-factor) for growth in vitro [2]. The disease is characterized by nasal discharge, sneezing, and facial edema, leading to significant economic losses in the poultry industry due to decreased egg production and increased culling rates [3]. While not a single molecular target itself, the bacterium contains various essential enzymes and pathways that are targeted by antimicrobial agents such as sulfonamides, tetracyclines, and fluoroquinolones [4]. Management typically involves strict biosecurity, antibiotic therapy for outbreaks, and the use of inactivated bacterin vaccines to provide serovar-specific protection [5].

Other names
Haemophilus paragallinarumInfectious Coryza agent
02

Mechanism of action

Inhibition of bacterial cell wall synthesis, protein synthesis, DNA replication, and folic acid metabolism

03

Biological functions

OtherPathogenesisRespiratory tract colonizationNAD-dependent metabolism
04

Disease associations

InfectionInfectious Coryza
05

Safety considerations

Development of antimicrobial resistanceLack of cross-protection between serovars in vaccinesEconomic impact of treatment withdrawal periods in food-producing animals
06

Interacting drugs

Sulfadimethoxine

5 more in the full profile.

07

Biomarkers

V-factor (NAD) requirementHpg-specific PCRHemagglutination inhibition (HI) antibody titers

Beyond the preview

Go deeper on Avibacterium paragallinarum (A. paragallinarum).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avibacterium paragallinarum (A. paragallinarum).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call